Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,991,000 | 6,085,000 | 5,412,000 | 5,338,000 | 5,997,000 |
| Marketable Securities | N/A | 1,179,000 | 973,000 | 1,182,000 | 1,411,000 |
| Receivables | 4,420,000 | 4,660,000 | 4,777,000 | 4,493,000 | 4,892,000 |
| Inventories | 1,710,000 | 1,787,000 | 1,507,000 | 1,618,000 | 1,683,000 |
| TOTAL | $19,173,000 | $16,085,000 | $14,443,000 | $14,772,000 | $15,996,000 |
| Non-Current Assets | |||||
| PPE Net | 5,414,000 | 5,317,000 | 5,475,000 | 5,121,000 | 4,967,000 |
| Investments And Advances | 0 | 1,163,000 | 1,245,000 | 1,309,000 | 502,000 |
| Intangibles | 28,262,000 | 34,768,000 | 37,208,000 | 41,787,000 | 41,234,000 |
| Other Non-Current Assets | 6,146,000 | 4,792,000 | 4,800,000 | 4,963,000 | 5,708,000 |
| TOTAL | $39,822,000 | $46,040,000 | $48,728,000 | $53,180,000 | $52,411,000 |
| Total Assets | $58,995,000 | $62,125,000 | $63,171,000 | $67,952,000 | $68,407,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,815,000 | 1,798,000 | 2,273,000 | 1,516,000 | 2,757,000 |
| Accounts payable and accrued liabilities | 833,000 | 550,000 | 905,000 | 705,000 | 844,000 |
| Accrued Expenses | 3,892,000 | 3,802,000 | 3,479,000 | 3,244,000 | 3,460,000 |
| Other current liabilities | 5,464,000 | 5,130,000 | 4,580,000 | N/A | N/A |
| TOTAL | $12,004,000 | $11,280,000 | $11,237,000 | $11,610,000 | $11,397,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,191,000 | 24,469,000 | 24,136,000 | 26,155,000 | 29,859,000 |
| Other Non-Current Liabilities | 830,000 | 2,091,000 | 3,942,000 | 4,791,000 | 5,050,000 |
| TOTAL | $27,745,000 | $28,096,000 | $30,725,000 | $35,278,000 | $38,789,000 |
| Total Liabilities | $39,749,000 | $39,376,000 | $41,962,000 | $46,888,000 | $50,186,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,245,346 | 1,245,775 | 1,247,105 | 1,253,887 | 1,256,593 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 11,497,000 | 16,304,000 | 15,687,000 | 16,324,000 | 14,381,000 |
| Other shareholders' equity | 48,000 | -56,000 | -29,000 | 78,000 | -41,000 |
| TOTAL | $19,246,000 | $22,749,000 | $21,209,000 | $21,064,000 | $18,221,000 |
| Total Liabilities And Equity | $58,995,000 | $62,125,000 | $63,171,000 | $67,952,000 | $68,407,000 |